Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BCBA/PFE stock hub

BCBA/PFE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BCBA/PFEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

203.8T

Buenos Aires Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BCBA/PFE

In the news

Latest news · BCBA/PFE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.9

P25 14.1P50 17.9P75 19.4

Trailing P/E19.8

P25 25P50 30P75 39

ROE8.3

P25 6.8P50 15.6P75 45.1

ROIC12.7

P25 9P50 19.1P75 21.2

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BCBA/PFE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

244

Groups with data

Currency

USD

Showing 244 of 244 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	75,000
Employees Change	-7,000%
Employees Change Percent	-7.95
Enterprise value	ARS 276.2T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	ARDEUT111424
Last refreshed	2026-05-10
Market cap	ARS 203.8T
Price	ARS 9,530
Price currency	ARS
Rev Per Employee	1,159,510,810.5x
Sector	Healthcare
Sic	2834
Symbol	bcba/PFE
Website	https://www.pfizer.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.05%
EV Earnings	26.84x
EV/EBIT	10.49x
EV/EBITDA	7.52x
EV/FCF	21.2x
EV/Sales	3.13x
FCF yield	6.39%
Forward P/E	8.86x
P/B ratio	1.64x
P/E ratio	19.81x
P/S ratio	2.34x
PE Ratio10 Y	18.93x
PE Ratio3 Y	24.51x
PE Ratio5 Y	18.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	29.87%
EBITDA Margin	40.21%
FCF margin	14.98%
Gross margin	74.8%
Gross Profit	ARS 65T
Gross Profit Growth	3.59%
Gross Profit Growth Q	-0.71%
Gross Profit Growth3 Y	-9.68%
Gross Profit Growth5 Y	5.93%
Net Income	ARS 10.3T
Net Income Growth	-4.97%
Net Income Growth Q	-9.44%
Net Income Growth Years	0%
Net Income Growth3 Y	-36.35%
Net Income Growth5 Y	-6.85%
Pretax Margin	12.49%
Profit Margin	11.83%
Profit Per Employee	ARS 137.2M
Profitable Years	41
ROA	5.69
Roa5y	7.03
ROCE	10.91
ROE	8.31
Roe5y	17.68
ROIC	12.72
Roic5y	18.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	59.04%
Cagr15y	53.23%
Cagr1y	52.1%
Cagr20y	39.96%
Cagr3y	34.36%
Cagr5y	46.69%
Div CAGR10	70.44%
Div CAGR3	113.06%
Div CAGR5	47.66%
EPS Growth	-5.1
EPS Growth Q	-10.05
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-36.28
EPS Growth5 Y	-7.08
FCF Growth	-15.48%
FCF Growth Q	23.04%
FCF Growth3 Y	-22.29%
FCF Growth5 Y	-6.79%
OCF Growth	-14.33%
OCF Growth Q	11.99%
OCF Growth10 Y	-2.74%
OCF Growth3 Y	-20.6%
OCF Growth5 Y	-5.39%
Revenue Growth	1.36x
Revenue Growth Q	5.37x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-12.08x
Revenue Growth5 Y	6.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.3
Assets	ARS 285.2T
Cash	ARS 18T
Current Assets	ARS 59.9T
Current Liabilities	ARS 48T
Debt	ARS 88.9T
Debt EBITDA	ARS 2.45
Debt Equity	ARS 0.72
Debt FCF	ARS 6.83
Equity	ARS 124.2T
Interest Coverage	7.04
Liabilities	ARS 161T
Long Term Assets	ARS 225.3T
Long Term Liabilities	ARS 113T
Net Cash	ARS -70.9T
Net Cash By Market Cap	ARS -34.8
Net Debt EBITDA	ARS 2.03
Net Debt Equity	ARS 0.57
Net Debt FCF	ARS 5.45
Tangible Book Value	ARS -46.5T
Tangible Book Value Per Share	ARS -8,162
WACC	5.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.25
Inventory Turnover	1.48
Net Working Capital	ARS -983.4B
Quick ratio	0.85
Working Capital	ARS 11.6T
Working Capital Turnover	ARS 9,726

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.26%
Dividend Growth	55.04%
Dividend Growth Years	4%
Dividend per share	ARS 438
Dividend Years	27
Dividend Yield	4.6%
Ex Div Date	2026-05-08
Last Dividend	ARS 150
Payout Frequency	Quarterly
Payout Ratio	130.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	10,247.65%
1Y total return	52.06%
200-day SMA	9,395.8
3Y total return	142.58%
50-day SMA	9,955.4
50-day SMA vs 200-day SMA	50over200
5Y total return	578.95%
All Time High	10,800
All Time High Change	-11.76%
All Time High Date	2025-10-01
All Time Low	9.25
All Time Low Change	102,927.03%
All Time Low Date	2001-09-19
ATR	256.2
Beta	0.31
Ch YTD	0.47
High	9,770
High52	10,800
High52 Date	2025-10-01
High52ch	-11.76%
Low	9,495
Low52	6,350
Low52 Date	2025-05-14
Low52ch	50.08%
Ma50ch	-4.27%
Price vs 200-day SMA	1.43%
RSI	37.88
RSI Monthly	58.7
RSI Weekly	48.26
Sharpe ratio	1.17x
Sortino ratio	1.94
Total Return	4.34%
Tr YTD	3.07
Tr15y	60,198.51%
Tr1m	-3.71%
Tr1w	-1.95%
Tr3m	-4.66%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ARS 26T
Operating Income Growth	20.65
Operating Income Growth Q	-5.27
Operating Income Growth3 Y	-18.95
Operating Income Growth5 Y	10.43
Operating margin	29.87

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,691,728,668%
Net Borrowing	3,123,203,128,661
Shares Insiders	0.03%
Shares Institutions	67.59%
Shares Qo Q	0.79%
Shares Yo Y	0.26%
Short Ratio	3.47

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 11.8T
Average Volume	22,707.45x
Bv Per Share	21,715
CAPEX	ARS -3.4T
Ch10y	7,858.2
Ch15y	42,492.2
Ch1m	-5.17
Ch1w	-3.44
Ch1y	43.31
Ch20y	50,524.2
Ch3m	-6.11
Ch3y	117.7
Ch5y	498.5
Ch6m	6.07
Change	-3.35%
Change From Open	-2.11
Close	9,860
Days Gap	-1.27
Depreciation Amortization	9,161,209,356,350
Dollar Volume	457,373,290
Earnings Date	2026-05-05
EBIT	ARS 26T
EBITDA	ARS 35T
EPS	ARS 1,803
F Score	6
FCF	ARS 13T
FCF EV Yield	4.72x
Financing CF	-10,895,995,332,500
Fiscal Year End	December
Founded	1,849
Goodwill	99,876,763,195,053
Graham Number	7926.69663
Graham Upside	-16.82
Income Tax	ARS 527.4B
Investing CF	-5,274,249,600,000
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-29
Last Split Date	2024-01-24
Last Split Type	Forward
Lynch Fair Value	ARS 2,405
Lynch Upside	-74.76
Ma150	9,737.1
Ma150ch	-2.13%
Ma20	9,918
Ma20ch	-3.91%
Net CF	383,207,197,500
Next Earnings Date	2026-07-28
Open	9,735
P FCF Ratio	15.65
P OCF Ratio	12.38
Payment Date	2026-06-12
Position In Range	12.73
Ppne	27,136,760,905,634
Price Date	2026-05-08
Price EBITDA	ARS 5.83
Relative Volume	2.25x
Revenue	86,963,310,787,500x
SBC By Revenue	1.42x
Share Based Comp	1,237,525,752,500
Tax By Revenue	0.61x
Tax Rate	4.86%
Tr20y	83,066.62%
Tr6m	8.8%
Volume	47,993
Z Score	2.17

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BCBA/PFE dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.6%

$438 annual per share

Payout ratio

+130.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+47.7%

4 consecutive years of growth

Total shareholder yield

+4.3%

Next ex-dividend date: 2026-05-08

Performance

BCBA/PFE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BCBA/PFE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+67.6%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BCBA/PFE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.9

Neutral momentum band

Price vs 200-day MA

+1.4%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

1.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BCBA/PFE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bcba/PFE stock rating?

bcba/PFE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bcba/PFE analysis?

The full report lives at /stocks/bcba/PFE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bcba/PFE?

The latest report frames bcba/PFE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bcba/PFE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.